Peer-Reviewed Journal Details
Mandatory Fields
Denihan, NM,Walsh, BH,Reinke, SN,Sykes, BD,Mandal, R,Wishart, DS,Broadhurst, DI,Boylan, GB,Murray, DM
2015
May
Clinical biochemistry
The effect of haemolysis on the metabolomic profile of umbilical cord blood
Validated
()
Optional Fields
Haemolysis Hemolysis Umbilical cord blood Metabolomics Biobanking
48
534
537
Objectives: Metabolomics is defined as the comprehensive study of all low molecular weight biochemicals, (metabolites) present in an organism. Using a systems biology approach, metabolomics in umbilical cord blood (UCB) may offer insight into many perinatal disease processes by uniquely detecting rapid biochemical pathway alterations. In vitro haemolysis is a common technical problem affecting UCB sampling in the delivery room, and can hamper metabolomic analysis. The extent of metabolomic alteration which occurs in haemolysed samples is unknown.Design and methods: Visual haemolysis was designated by the laboratory technician using a standardised haemolysis index colour chart. The metabolomic profile of haemolysed and non-haemolysed UCB serum samples from 69 healthy term infants was compared using both H-1-NMR and targeted DI and LC-MS/MS approach.Results: We identified 43 metabolites that are significantly altered in visually haemolysed UCB samples, acylcarnitines (n = 2), glycerophospholipids (n = 23), sphingolipids (n = 7), sugars (n = 3), amino acids (n = 4) and Krebs cycle intermediates (n = 4).Conclusion: This information will be useful for researchers in the field of neonatal metabolomics to avoid false findings in the presence of haemolysis, to ensure reproducible and credible results. (C) 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
10.1016/j.clinbiochem.2015.02.004
Grant Details